№ files_lp_4_process_1_27541
File format: docx
Character count: 8278
File size: 32 KB
Filed as part of a securities transaction disclosure, this document reports ownership details and affiliated entities according to Schedule 13G under the Securities Exchange Act.
Year:
2025
Region / City:
Washington, D.C.
Topic:
Securities Filings
Document Type:
Regulatory Filing
Issuer:
SMITH (AO) CORP
Author:
FMR LLC, Abigail P. Johnson
Target Audience:
Regulatory Authorities, Financial Institutions
Period of Action:
12/31/2025
Date of Approval:
02/04/2026
Date of Changes:
02/04/2026
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2025
Jurisdiction:
United States
Filing Entity:
Royce & Associates LP
Issuer:
Viant Technology Inc
Address of Issuer:
2722 Michelson Drive Suite 100, Irvine, CA, 92612
CUSIP:
92557A101
Class of Securities:
Class A Common Stock
Event Date:
12/31/2025
Percentage of Class Owned:
5.47%
Sole Voting Power:
912,043
Shared Voting Power:
0
Sole Dispositive Power:
912,043
Shared Dispositive Power:
0
Type of Reporting Person:
IA
Principal Business Address of Filer:
One Madison Avenue, New York, NY 10010
Citizenship/Place of Organization:
New York
Signature Date:
01/21/2026
Context:
SEC Schedule 13G filing reporting beneficial ownership and voting authority of Class A common stock by an investment adviser.
Year:
2025
Date of Event Which Requires Filing of this Statement:
October 31, 2025
Amendment Number:
3
Issuing Authority:
Securities and Exchange Commission
Type of Document:
Schedule 13G filing
Governing Law:
Securities Exchange Act of 1934
Issuer:
Praxis Precision Medicines, Inc.
Issuer Address:
99 High Street, 30th Floor, Boston, MA 02110
Title of Class of Securities:
Common Stock, par value $0.0001 per share
CUSIP Number:
74006W207
Outstanding Shares Referenced:
24,693,005
Reporting Persons:
Adage Capital Management, L.P.; Robert Atchinson; Phillip Gross
Place of Organization:
Delaware
Citizenship:
United States
Business Address of Reporting Persons:
200 Clarendon Street, 52nd Floor, Boston, Massachusetts 02116
Aggregate Amount Beneficially Owned:
1,305,175 shares
Percent of Class Represented:
5.29%
Filing Category:
Rule 13d-1
SEC File References:
Prospectus filed pursuant to Rule 424(b)(5) on October 20, 2025; Current Report on Form 8-K filed October 20, 2025
Year:
2025
Region / City:
Washington, D.C.
Topic:
Securities filing
Document Type:
Regulatory filing
Issuer:
Sotera Health Co
Author:
BlackRock, Inc.
Target Audience:
Regulatory bodies, investors
Period of Action:
12/31/2025
Approval Date:
01/21/2026
Modification Date:
None
Issuer:
PLAINS GP HOLDINGS, L.P.
Title of Securities:
Common Stock
CUSIP Number:
72651A207
Date of Event:
12/31/2025
Filer:
Massachusetts Financial Services Company
Place of Filing:
Delaware
Number of Shares Beneficially Owned:
9,537,077
Voting Power:
Sole Voting Power: 9,516,370, Shared Voting Power: 0
Dispositive Power:
Sole Dispositive Power: 9,537,077, Shared Dispositive Power: 0
Percentage of Class:
4.8%
Filing Date:
01/28/2026
Nature of Filing:
Schedule 13G
Year:
2009
Jurisdiction:
United States
Document Type:
SEC Filing
Issuer:
Callaway Golf Company
Reporting Persons:
Angelo, Gordon & Co., L.P.; John M. Angelo; Michael L. Gordon
Security Type:
Common Stock, $0.01 par value
CUSIP:
131193104
Filing Date:
December 31, 2009
Ownership Percentage:
5.05%
Address of Issuer:
2180 Rutherford Road, Carlsbad, CA 92008
Address of Reporting Persons:
245 Park Avenue, New York, NY 10167
Citizenship of Reporting Persons:
Delaware (Angelo, Gordon & Co., L.P.), United States (John M. Angelo, Michael L. Gordon)
Roles of Reporting Persons:
Investment Adviser, Control Persons
Aggregate Shares Beneficially Owned:
3,429,788
Related Fund:
Private investment fund advised by Angelo, Gordon & Co.
Year:
2026
Issuer:
Bitfarms Ltd.
CUSIP:
09173B107
Security Type:
Common Shares
Event Date:
02/05/2026
Reporting Persons:
Citadel Securities GP LLC, Citadel Securities LLC, Citadel Securities Group LP, Citadel Advisors LLC, Citadel Advisors Holdings LP, Citadel GP LLC, Kenneth Griffin
Citizenship / Place of Organization:
Delaware, United States, Ireland
Aggregate Shares Reported:
23,740,167 to 23,739,533 depending on filer
Percent of Class:
0.0% to 112.9% depending on filer
Type of Reporting Person:
HC, OO, BD, OOS, PNS, IA, INS
Principal Executive Office of Issuer:
110 Yonge Street, Suite 1601, Toronto, Ontario, Canada, M5C 1T4
Principal Business Office of Reporting Persons:
830 Brickell Plaza, Miami, Florida 33131
Filing Status:
Joint Filing
Date Filed with SEC:
February 5, 2026
Year:
2025
Issuer:
Jefferson Capital, Inc.
CUSIP:
47248R103
Title of Securities:
Common Stock, $0.0001 par value per share
Reporting Persons:
JCF IV JCAP Holding L.P., JCF IV JCAP Holding GP LLC, JCF Associates IV L.P., JCF Associates IV Ltd., J. Christopher Flowers
Citizenship/Place of Organization:
Delaware, Cayman Islands, United States
Shares Beneficially Owned:
43,721,808
Percent of Class:
75.0%
Principal Business Address of Reporting Persons:
c/o J.C. Flowers & Co., 1301 Avenue of the Americas, 16th Floor, New York, New York 10019
Type of Document:
SEC Schedule 13G Filing
Filing Date:
November 14, 2025
Event Date:
September 30, 2025
Exhibits:
Joint Filing Agreement, dated November 14, 2025
Year:
2025
Region / City:
Washington, D.C., United States
Subject:
Securities ownership reporting
Document Type:
SEC filing
Issuing Authority:
Securities and Exchange Commission
Issuer:
ThredUp Inc.
Filing Entity:
Capital World Investors
CUSIP Number:
88556E102
Title of Securities:
Common Stock
Beneficial Ownership:
8,707,600 shares (8.4% of class)
Reporting Date:
12/31/2025
Signature Date:
02/10/2026
Authorized Signatory:
Timothy J. Moon, Vice President and Senior Counsel, Capital Research and Management Company
Year:
2025
Country:
United States
City:
Washington, D.C.
Issuer:
Upstart Holdings, Inc.
Issuer Address:
2950 S. Delaware Street, Suite 410, San Mateo, CA 94403
Type of Document:
Schedule 13G beneficial ownership report
Regulatory Authority:
U.S. Securities and Exchange Commission
Legal Basis:
Securities Exchange Act of 1934
Security Type:
Common Stock, $0.0001 par value per share
CUSIP:
91680M107
Date of Event:
December 31, 2025
Reporting Persons:
G1 Execution Services, LLC; SIG Brokerage, LP; Susquehanna Portfolio Strategies, LLC; Susquehanna Securities, LLC
Organizational Jurisdiction:
Illinois; Delaware
Aggregate Beneficial Ownership:
4,554,175 shares
Ownership Percentage:
4.6% of class
Filing Category:
Rule 13d-1(b), Rule 13d-1(c), Rule 13d-1(d)
Affiliated Entities:
Susquehanna Portfolio Strategies, LLC; Susquehanna Securities, LLC; SIG Brokerage, LP; G1 Execution Services, LLC
Principal Business Offices:
Chicago, Illinois; Bala Cynwyd, Pennsylvania
Year:
2025
Region / City:
United States / Washington, D.C.
Theme:
Securities, Investment Management
Document Type:
Financial Filing
Organization / Institution:
Securities and Exchange Commission
Author:
AQR Capital Management, LLC, AQR Capital Management Holdings, LLC, AQR Arbitrage, LLC
Target Audience:
Investors, Regulatory Authorities
Effective Period:
12/31/2025
Approval Date:
02/12/2026
Modification Date:
N/A
Year:
2018
Region / City:
Hollywood, FL
Subject:
Securities Filing
Document Type:
SEC Filing
Organization / Institution:
Securities and Exchange Commission
Author:
BlackRock, Inc.
Target Audience:
Investors, SEC Filers
Effective Period:
December 31, 2018
Approval Date:
February 8, 2019
Date of Changes:
February 8, 2019
Year:
2026
Jurisdiction:
United States, Delaware
Issuer:
GigCapital9 Corp.
CUSIP:
G3865B106
Type of Filing:
Schedule 13G
Reporting Persons:
Harraden Circle Investments, LLC; Harraden Circle Investors GP, LP; Harraden Circle Investors GP, LLC; Harraden Circle Investors, LP; Harraden Circle Special Opportunities, LP; Harraden Circle Strategic Investments, LP; Harraden Circle Concentrated, LP; Frederick V. Fortmiller, Jr.
Shares Reported:
2,568,800 to 62,568,800 depending on reporting person
Percent of Class:
0.65% to 19.99%
Role:
Investment managers and affiliated entities of Harraden Circle
Filing Date:
2026-01-27
Address of Issuer:
1731 Embarcadero Rd., Suite 200, Palo Alto, CA, 94303
Document Type:
Regulatory filing with SEC under Securities Exchange Act of 1934
Agency:
United States Securities and Exchange Commission
Form number:
Form 25
Document type:
Regulatory filing form
Jurisdiction:
United States
Legal basis:
Securities Exchange Act of 1934
Applicable rules:
Rule 12d2-2 (17 CFR 240.12d2-2); Rule 19d-1 (17 CFR 240.19d-1)
OMB control number:
3235-0080
OMB expiration date:
March 31, 2021
Filing system:
EDGAR
Effective delisting period:
10 days after filing
Effective withdrawal of registration period:
90 days after filing
Revision identifier:
SEC 1654 (03-06)
Year:
2021
Region / city:
Panama City, Republic of Panama
Topic:
Financial Report
Document Type:
Press Release
Organization:
Banco Latinoamericano de Comercio Exterior, S.A.
Author:
Bladex Communications
Target Audience:
Investors, financial analysts
Period of validity:
Q2 2021, 6M 2021
Approval Date:
July 29, 2021
Date of Changes:
None
Year:
2024
Region / city:
Delaware, USA
Theme:
Business operations, financial report
Document type:
Annual report
Institution:
U.S. Securities and Exchange Commission
Author:
BAB, Inc.
Target audience:
Investors, financial analysts, regulators
Period of validity:
Fiscal year ending November 30, 2024
Approval date:
Not specified
Date of amendments:
Not specified
Document type:
Regulatory compliance checklist
Governing law:
Securities Exchange Act of 1934
Applicable rules:
SEA Rules 17a-3 and 17a-4
Regulatory authority:
U.S. Securities and Exchange Commission
Related organization:
Financial Industry Regulatory Authority
Subject matter:
Broker-dealer books and records requirements
Jurisdiction:
United States
Retention periods:
Three to six years depending on record type
Target entities:
Registered broker-dealers
Source references:
SEA Rule 17a-3; SEA Rule 17a-4
Compliance focus:
Record creation and retention
Year:
2022
Region / City:
Panama City, Republic of Panama
Topic:
Foreign trade, financial reporting
Document Type:
Report
Organization:
Banco Latinoamericano de Comercio Exterior, S.A.
Author:
Ana Graciela de Méndez
Target Audience:
Investors, financial institutions
Period of Validity:
April 2022
Approval Date:
April 28, 2022
Date of Changes:
April 28, 2022
Contextual Description:
A financial report by Banco Latinoamericano de Comercio Exterior, S.A. detailing the submission of their annual report on Form 20-F to the U.S. Securities and Exchange Commission for the fiscal year 2021.
Year:
2025
Region / city:
United States, Washington D.C.
Subject:
Financial Reporting
Document Type:
Quarterly Report
Organization / institution:
U.S. Securities and Exchange Commission
Author:
Eli Lilly and Company
Target audience:
Investors, Financial Analysts
Period of validity:
Quarter ending September 30, 2025
Approval Date:
Not specified
Date of changes:
Not specified
Description:
Financial report detailing the financial status, results of operations, and other corporate disclosures for Eli Lilly and Company for the third quarter of 2025.
Year:
2025
Region / City:
Thousand Oaks, California
Topic:
Financial Report
Document Type:
Quarterly Report
Organization:
Amgen Inc.
Author:
Amgen Inc.
Target Audience:
Investors, Financial Analysts
Period of Validity:
Quarter ended June 30, 2025
Approval Date:
Not specified
Date of Changes:
Not specified
Context Description:
Financial report for Amgen Inc., filed in accordance with the Securities Exchange Act of 1934.
Year:
2025
Date of Event Which Requires Filing of this Statement:
October 31, 2025
Amendment Number:
3
Issuing Authority:
Securities and Exchange Commission
Type of Document:
Schedule 13G filing
Governing Law:
Securities Exchange Act of 1934
Issuer:
Praxis Precision Medicines, Inc.
Issuer Address:
99 High Street, 30th Floor, Boston, MA 02110
Title of Class of Securities:
Common Stock, par value $0.0001 per share
CUSIP Number:
74006W207
Outstanding Shares Referenced:
24,693,005
Reporting Persons:
Adage Capital Management, L.P.; Robert Atchinson; Phillip Gross
Place of Organization:
Delaware
Citizenship:
United States
Business Address of Reporting Persons:
200 Clarendon Street, 52nd Floor, Boston, Massachusetts 02116
Aggregate Amount Beneficially Owned:
1,305,175 shares
Percent of Class Represented:
5.29%
Filing Category:
Rule 13d-1
SEC File References:
Prospectus filed pursuant to Rule 424(b)(5) on October 20, 2025; Current Report on Form 8-K filed October 20, 2025